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Cerebral hemorrhages are common features of traumatic brain injury (TBI) and their
presence is associated with chronic disabilities. Recent clinical and experimental
evidence suggests that haptoglobin (Hp), an endogenous hemoglobin-binding protein
most abundant in blood plasma, is involved in the intrinsic molecular defensive
mechanism, though its role in TBI is poorly understood. The aim of this study was to
investigate the effects of Hp deletion on the anatomical and behavioral outcomes in
the controlled cortical impact model using wildtype (WT) C57BL/6 mice and genetically
modified mice lacking the Hp gene (Hp−/−) in two age cohorts [2–4 mo-old (young adult)
and 7–8 mo-old (older adult)]. The data obtained suggest age-dependent significant
effects on behavioral and anatomical TBI outcomes and recovery from injury. Moreover,
in the adult cohort, neurological deficits in Hp−/− mice at 24 h were significantly improved
compared to WT, whereas there were no significant differences in brain pathology
between these genotypes. In contrast, in the older adult cohort, Hp−/− mice had
significantly larger lesion volumes compared to WT, but neurological deficits were
not significantly different. Immunohistochemistry for ionized calcium-binding adapter
molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) revealed significant differences
in microglial and astrocytic reactivity between Hp−/− and WT in selected brain regions of
the adult but not the older adult-aged cohort. In conclusion, the data obtained in the study
provide clarification on the age-dependent aspects of the intrinsic defensive mechanisms
involving Hp that might be involved in complex pathways differentially affecting acute
brain trauma outcomes.
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INTRODUCTION
Traumatic brain injury (TBI) is one of the major causes of morbidity and mortality
in the United States and worldwide with no current effective treatment. It is widely
recognized that chronic neurological and psychological disabilities following TBI largely result
from potentially preventable or treatable secondary pathophysiological cascades, so-called
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secondary injuries, initiated by the acute brain trauma.
However, despite extensive research and promising results
obtained in preclinical studies, numerous clinical trials failed
primarily due to the heterogeneity and complexity of the TBI
and mechanisms underlying acute vs. chronic anatomical
pathologies and neurological deficits. Secondary injuries
resulting from acute TBI, such as mechanical brain damage and
intracranial hemorrhages, are triggered by complex coexisting
pathways involving excitotoxicity, oxidative damage, and
neuroinflammatory cascades (McIntosh et al., 1996; Diaz-
Arrastia et al., 2000; Saatman et al., 2008). On the other hand,
the presence of acute subarachnoid or, to a lesser degree,
parenchymal hemorrhages following TBI is highly associated
with brain-injury severity and chronic cognitive and physical
disabilities; and it is believed that the mechanisms are mainly
initiated by the toxicity of hemoglobin and its heme-containing
breakdown products released into the brain tissues from
erythrocytes during hemolysis of cerebral hematomas (Xi
et al., 1998; Bhasin et al., 2002), causing oxidative damage
to macromolecules such as lipids, proteins, and nucleic acids
(Nakamura et al., 2005, 2006), as well as activation caspase
proteolysis (Regan and Panter, 1993; Wang et al., 2002),
resulting in disruption of the blood-brain barrier (Xi et al.,
1998; Bhasin et al., 2002; Keep et al., 2008) and neuronal death
(Koeppen et al., 1995; Aronowski and Hall, 2005; Xi et al., 2006).
One of the critical mechanisms involved in deactivation
of cell-free hemoglobin in the mammalian body during the
hemorrhagic event is formation of highly stable complexes
of hemoglobin with haptoglobin (Hp)—an endogenous
hemoglobin-binding protein present in blood plasma and almost
absent within the brain itself (Wada et al., 1970; Philippidis
et al., 2004; Schaer et al., 2006)—and subsequent clearance of
the Hp-hemoglobin complexes primarily by tissue macrophages
and circulating monocytes, and likely by other cell types such
as astrocytes and microglial cells that are mediated via CD163
(Liu and Sturner, 1988; D’Armiento et al., 1997; Ascenzi et al.,
2005; Schaer et al., 2005, 2007; Zhang et al., 2012). However, at
this point, the contribution of Hp to acute brain injury is still not
fully understood (D’Armiento et al., 1997).
The changes in Hp expression have been shown in various
disorders and diseases associated with inflammation (Carter and
Worwood, 2007). It is well recognized that under physiological
conditions the plasma pool of Hp is relatively high and its
levels further increase up to 10-fold in different types of
injuries associated with hemorrhages as a part of the acute
phase-2 response (Petersen et al., 2004). Early studies have
shown that serum Hp concentrations are increased in patients
with severe head injuries and that the serum Hp level could
potentially be a predictive biomarker of the hemorrhagic brain-
lesion severity (Auer and Petek, 1978). In both physiological
and pathophysiological conditions, Hp is synthesized mainly
by hepatocytes and then released to the peripheral circulation
(Bowman and Kurosky, 1982; Hoj et al., 1984; Yang et al.,
2013). However, some studies suggest that Hp may have very
limited expression within brain-cell types. The Hp mRNAs were
found in the human retinal pigment epithelial cell line and
post-mortem neural retina (Chen et al., 1998). Expression of
Hp has also been demonstrated in human glioblastoma tissue
but not in normal brain samples (Kumar et al., 2010). Few
groups have documented that Hp is present within the brain
of rodents following brain injuries (Lee et al., 2002; Zhao
et al., 2009, 2011). Mouse studies from Dr. J. Aronowski and
colleagues suggested that Hp is expressed and secreted by brain
oligodendrocytes after experimental intracerebral hemorrhage
and that brain-derived Hp plays a significant role in the
protection of brain cells after injury (Zhao et al., 2009, 2011) in
addition, a rat study by Dr. Kim and colleagues suggested Hp
expression in the hippocampus following brain ischemia (Lee
et al., 2002). Increased Hp immunoreactivity and upregulation
of Hp mRNA in reactive astrocytes have been shown in an
experimental ischemia model, suggesting de novo Hp synthesis
in the brain (Lee et al., 2002). On the other hand, a human
study of subarachnoid hemorrhage suggested an influx of Hp
from peripheral circulation into cerebrospinal fluid, and that the
intrathecal Hp-scavenging system could have limited capacity
(Galea et al., 2012). Previously, Hp levels in cerebrospinal fluid
have been proposed as a biomarker of blood-brain barrier
disruption (Chamoun et al., 2001). It has also been demonstrated
that, following TBI, the increase in brain Hp levels occurs
due to extravasation of Hp, as well as other types of plasma
proteins, into brain parenchyma resulting from the blood-brain
barrier breakdown associated with intracranial hemorrhage and
subsequent uptake of the plasma proteins by reactive astrocytes
(Liu and Sturner, 1988).
Current interest is driven by recent studies suggesting that
Hp phenotypes, primarily associated with different affinities to
bind free hemoglobin and affinity of the hemoglobin-Hp complex
to its receptors, may be associated with differential outcomes in
subarachnoid hemorrhages (Chaichana et al., 2007, 2010; Leclerc
et al., 2015) and that Hp may play an important role in the
development of secondary injuries, particularly delayed arterial
vasospasm and brain ischemia (Nonaka et al., 1979; Borsody
et al., 2006). Of interest, post-traumatic cerebral vasospasm is
a common complication of TBI, with incidences ranging from
2 to 63% mainly depending on the severity of injury and the
method of diagnostics (Macpherson and Graham, 1978; Taneda
et al., 1996; Mattioli et al., 2003). Although there is a strong
association of cerebral vasospasm with traumatic subarachnoid
hemorrhage (Macpherson and Graham, 1978; Gomez et al., 1991;
Steiger et al., 1994; Kordestani et al., 1997; Aminmansour et al.,
2009), it is also common in patients with subdural hematomas,
intraventricular hemorrhage, and contusions (Mattioli et al.,
2003; Oertel et al., 2005; Kalanuria et al., 2013). In general,
subarachnoid hemorrhages are associated with extremely high
rates of mortality of about 45–50%, significant morbidity exists
among survivors (van Gijn et al., 2007; Bederson et al., 2009)
and chronic disabilities are common (Kantor et al., 2014).
It should be noted that subarachnoid hemorrhage associated
with TBI accounts for about half of all cases, and subsequent
cerebral vasospasm following both aneurysmal and traumatic
subarachnoid hemorrhages is among the leading causes of
morbidity and mortality with no proven effective treatment
(Suarez et al., 2006; Amyot et al., 2015). Thus, identifying
the mechanisms underlying TBI pathologies and intrinsic,
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potentially protective responses involving acute reactants, such
as Hp (Vejda et al., 2002; Campbell et al., 2005), will provide
new insights into the development of novel strategies for TBI
treatment.
Experimental and clinical data suggest that Hp phenotypes are
differentially associated with occurrence of cerebral vasospasm,
a common complication of subarachnoid hemorrhage, and that
the patients with increased risk might be identified based on
their Hp genotype (Chaichana et al., 2007, 2010; Leclerc et al.,
2015). The human and mouse Hp cDNAs share homology
of >80%, and although mice are homomorphic for the Hp
genotype expressing only a “high” affinity Hp1–1 phenotype, Hp
phenotypes were associated with differential neuropsychological
outcomes after TBI; however, in this case, the Hp 1–1 phenotype,
which is characterized by the highest affinity to hemoglobin, was
associated with worse outcomes (Lee et al., 2002; Anderson et al.,
2009).
Although Hp is implicated in the pathophysiology of different
brain injuries, the published data suggest that its roles are
complex, that upregulation of Hp might have either or both
beneficial and detrimental effects, and that the outcomesmight be
predisposed by certain Hp genotypes. Thus, taking into account
the heterogeneity of Hp phenotypes in humans, the goal of this
preclinical study was to investigate the role of the “high” efficacy
Hp phenotype in a controlled cortical impact (CCI) model of TBI
using wild type (WT) C57BL/6 mice and genetically modified
mice of the same background lacking the Hp gene (Hp−/−)
and comparing anatomical and gliosis outcomes in two different
adult-age cohorts.
MATERIALS AND METHODS
Experimental Animals
Two matched age cohorts [i.e., 2–4 mo-old (adult) and 7–8 mo-
old (older adult)] of WT and Hp−/− C57BL/6 male mice were
used in the study. Hp−/− mice were maintained in the in-house
facility from the breeding stock provided by Dr. E. Tolosano.
The number of WT animals per group used for assessment of
anatomical and immunohistochemical analyses were as follows:
sham n = 5 and n = 5, and CCI n = 8 and n = 10 in the
adult (2–4 mo-old) and older adult (7–8 mo-old) age cohorts,
respectively. The number of Hp−/− mice per CCI group used for
assessment of anatomical and immunohistochemical outcomes
per group for analyses were n = 9 and n = 4 in the adult and
older adult age cohorts, respectively. In addition, small groups of
sham Hp−/− mice of both ages were used to confirm negligible
effects of craniotomy. For assessment of the behavioral outcomes,
the mice numbers were slightly inflated due to intrinsic mouse
variability of the behavioral outcome measures and confirmation
of behavioral test results. The numbers of animals used in the
analyses are indicated in the figure legends. The experiments
and procedures were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
procedures used in this study were approved by The University
of Florida Institutional Animal Care and Use Committee. All
surgery was performed under anesthesia, and all efforts were
made to minimize the pain and distress of the experimental
animals.
CCI Procedures
In this study, we used the same CCI or sham procedures
as previously described (Glushakov et al., 2013). Briefly, mice
were anesthetized with 4% isoflurane and maintained with 2%
isoflurane during all surgery procedures. Mice were placed in
the stereotaxic apparatus and the experimental contusive TBI
of mild-to-moderate severity was induced using a conventional
CCI model (PCI3000 PinPoint Precision Cortical Impactor,
Hatteras Instruments, Cary, NC, USA) with an impact tip
diameter of 3 mm, velocity of 3m/s, and compression distance
and time of 1mm and 100ms, respectively (Yu et al., 2009).
The experimental injury in all cases was induced in the right
hemisphere. Sham-injured mice underwent only the anesthesia
and craniotomy surgeries. After closing the incision, the mice
were removed from the stereotaxic apparatus, received an
intraperitoneal injection of warm saline to prevent dehydration,
and were placed into a temperature-controlled recovery chamber
for at least 1 h before being transferred to the animal housing
facility.
Neurobehavioral Deficits
Neurobehavioral deficits were assessed 24 and 48 h after CCI
or sham procedures using a 24-point Neurological Deficit Score
(NDS) scale as described in detail elsewhere (Glushakov et al.,
2013). Briefly, the assessment comprised six tests, including body
symmetry, gait, circling behavior, climbing on the incline plane,
and tail suspension tests to access compulsory circling and front
limb symmetry. Each of these individual tests was scored between
0 and 4 points for normal performance (score 0) and according
to criteria of gradually increased severity from score 1 to 4; the
NDS was calculated as a sum score obtained from the assessment.
Prior to behavioral testing, the animals were allowed to acclimate
in the testing room for about 30 min. For quantitative assessment
of stereotypic activity and circling behavior, the neurobehavioral
assessment was based on the moving pattern criteria used in the
individual circling behavior test performed on the open bench
top, which included a part of the NDS test. The circling behavior
test preceded all other behavioral tests. The mouse was placed on
the elevated open rectangular plane surface and allowed to move
freely for at least for 2–5 min depending on the animal’s moving
activity. The activity was videotaped from above and analyzed off-
line by a blinded examiner. The number of left and right turns
was counted for at least for 2 min or for a longer time period to
obtain a total number of turns of at least about 20. Preferential
turns to one side are indicative of stereotypic movement or
circling behavior. The activity values were calculated as a
total number of left and right turns per minute, and the
circling behavior values were calculated as a percentage of right
turns.
Brain Histopathology and
Immunohistochemistry
All mice used in the study were euthanized at 48 h and
processed for quantitative stereological brain pathology using
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cresyl violet staining and immunohistochemistry as described
before (Glushakov et al., 2014). All slides (eight 30-µm-thick
brain sections per slide cut from the same animal and spaced
about 500 µm apart) were scanned using ScanScope (Aperio
Technologies, Vista, CA, USA) and analyzed using ImageScope
software (Aperio) in a blinded manner. The volumes of cortical
lesions and tissue loss were estimated within 2-mm-thick brain
segments positioned between the bregma and 2mm posterior to
the bregma (i.e., bregma coordinates from 0 to−2mm). Cortical
lesions were defined as histological alterations in the ipsilateral
cortical structures within the site of impact and proximate areas
characterized by abnormal cellular morphology and irregular
cell density compared to the histological characteristic of their
corresponding contralateral counterparts, and, in some cases,
the presence of diffuse parenchymal hemorrhages and small
hematomas, whereas cavitation was defined as complete loss of
cortical tissue or the presence of enlarged hematomas without
evident existence of cresyl violet staining. The volume of
cortical injury was defined as a combined volume comprising
the volumes of cortical lesions and cavitation. Hippocampal
edema was assessed by measuring the volumes of ipsilateral and
contralateral hippocampi as described before (Glushakov et al.,
2013).
Reactive astrogliosis and microglial activation were assessed
using immunohistochemistry for glial fibrillary acidic protein
(anti-GFAP, 1:1000 DAKO, Carpinteria, CA, USA) and for
ionized calcium-binding adapter molecule 1 (anti-Iba1, 1;100,
Wako Bioproducts, Richmond, VA, USA), respectively; vector
kits were then used for DAB antigen visualization (Vector
Laboratories, Burlingame, CA, USA). Immunoreactivity was
calculated as a sum of positive and strong positive pixels in
rectangular selections (500 × 500 µm) in selected brain regions
with characteristic microglial and astrocytes morphological
changes. The brain regions were identified using Allen Mouse
Brain Atlas. To compare the astroglial and microglial reactivity
distribution in the anteroposterior directions from the midline
of cortical impact (between −1 and −2 mm from the bregma)
coordinates, the assessment was performed in about 1-mm-thick
brain segments starting from the bregma posteriorly (from 0 to
−4 bregma coordinates). To calculate relative immunoreactivity,
the images of two to three sections for each segment from each
brain slide (i.e., up to eight sections per animal) were analyzed
separately and themean data for each section in each animal were
included in group analysis.
Statistical Analyses
The power analysis to determine approximate minimal group
size was performed based on the assumption of obtaining
statistical significance of anticipated differences of means equal
to at least 1.5 standard deviation with a significance level
of α = 0.05 and a power of 1−ß = 0.80. To compare
the differences between anatomical and immunohistochemical
outcomes and locomotor activity in mice groups with different
surgical procedure (i.e., sham and CCI), genotype (i.e., WT
and HP−/−), and age (i.e., young adult and older adult),
the data were analyzed using multi-factor analysis of variance
(ANOVA) performed by mixed model regression data analysis
and Turkeys post-hoc comparison test between matched groups.
To compare the differences between non-parametric NDS data, a
series of ANOVA on ranks and Dunn’s post-hoc test were been
performed, taking into consideration multiple aforementioned
factors (i.e., surgical procedure, age, and genotype) and repeated
measurements. All parametric data are presented as the mean ±
standard error, and non-parametric data as median, range,
and interquartile range (IQR). P-values less than 0.05 were
considered significant (Macleod et al., 2009). Statistical analyses
were performed using JMP (SAS Institute Inc., Cary, NC, USA)
and GraphPad (GraphPad Software Inc., La Jolla, CA, USA)
software.
RESULTS
Effects of the Hp Knockout on
Neurobehavioral Outcomes Following CCI
in Different Age Cohorts
Neurological deficits after experimental TBI were assessed 24
and 48 h after CCI using the NDS and the differences between
multiple group factors, including surgery type and age with
repeated outcome measures, which were assessed using a series
non-parametric multi-factor ANOVA on ranks and post-hoc
Dunn’s rank sum test. In adult mice (2–4 mo-old), the median
NDS values in the CCI group at 24 and 48 h were 5 at both
time points (IQRs: 4–7 and 3–8, respectively), and these values
were significantly different (P < 0.0001 and P = 0.0001) from
those observed in the mice from the sham group with median
values of 0 at both time points (IQRs: 0–2 and 0–1, respectively;
Figure 1A). In older adult mice (7–8 mo-old), the median NDS
values at 24 and 48 h were 7 (IQR: 5–8) and 8 (IQR: 5–10),
respectively, although the NDS values in the CCI group were
not significantly different from those observed in the sham
group (Figure 1B). Although the median values were similar
at both time points (7 and 8), the NDS 48 h after CCI was
characterized by increased variability (IQRs: 2–5 and 0–10 24
and 48 h after surgery, respectively). In this age cohort, the
same animals 48 h after surgery showed worse NDS in the CCI
and sham groups, resulting in a wider NDS value range and
a lack of statistical significance. As compared to the 48 h NDS
scores, the median values were similar to those at the 24 h time
point. In addition, further analyses of time dependency based
on 24 and 48 h comparisons revealed no significant differences
between NDS values at these time points in the sham or CCI
group of the adult or older adult mice cohort (Figure 1C).
The NDS values for the sham and CCI groups were higher
compared to their counterpart groups of 2–4 mo-old mice. These
values were significantly different (P < 0.05) only at the 48 h
time point. No significant differences were observed between
the sham groups of adult and older adult animals at any time
point.
Based on the anatomical brain pathology of marked lesions
and tissue loss in the ipsilateral motor cortex observed in the CCI
model, we performed an analysis of locomotor activity pattern
by counting the number of left and right turns of free-moving
mice to quantitatively assess the circling behavior associated with
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FIGURE 1 | Age-dependent effects of the experimental TBI on neurobehavioral outcomes. (A-C) Comparison of NDS assessed at 24 and 48 h after the
experimental injury between sham- and CCI-injured WT mice in adult and older adult age cohorts (A,B), and between CCI-injured WT mice of different ages (C).
Statistical comparison of combined data presented in the (A-C) using a series of non-parametric multi-factor ANOVA with repeated measurement structure. The
numbers shown on the graphs represent P-values from the post-hoc statistical analyses performed using non-parametric Dunn’s rank sum test. (D-F) Comparison of
the circling behavior presented as the fraction of the right turns between sham- and CCI-injured WT mice in adult and older adult age cohorts (D,E), and between
CCI-injured WT mice of different ages (F), respectively. Statistical comparison of combined data using mixed model multi-factor ANOVA with repeated measurement
structure. P-values shown on the graphs between two groups used for pairwise comparison were obtained from the statistical analyses using the post-hoc Student’s
t-test. In all panels, the numbers of animals per sham and CCI experimental groups of WT mice used for analyses were as follows: n = 6 and n = 18 in the adult mice
age cohort (2–4 mo-old), and n = 5 and n = 13 in the older adult mice age cohort (7–8 mo-old), respectively.
unilateral impairment of this brain region (Figures 1D,E). The
analyses of stereotypic movement behavior and activity in the
group of mice used for NDS assessment using mixed model
multi-factor ANOVA revealed a significant temporal effect (P =
0.0009), although the post-hoc comparison between matching
groups using Student’s t-test revealed no significant differences
between groups. There were no significant differences between
proportions of left and right turns between the sham and CCI
groups 48 h after experimental injury or in each group between
the 24 and 48 h time points in both age cohorts. Similarly,
in both age cohorts, there were no significant differences
between locomotor activity calculated as the number of left and
right turns or total number of left and right turns combined
between the sham and CCI groups or in each group between
24 and 48 h time points (data not shown). To compare the
differences between experimental groups, the values of moving
symmetry were expressed as a percentage fraction of right
turns. Mixed model multi-factor ANOVA revealed a significant
temporal effect (P = 0.0009). However, post-hoc comparison
between matching groups also revealed no statistically significant
differences between outcomes in the CCI groups from adult
and older adult cohorts at both 24 and 48 h time points
(Figure 1F).
Figures 2A-C demonstrate the comparison of NDS between
WT and Hp−/− CCI-injured mice. A series of non-parametric
multi-factor ANOVA and post-hoc comparison between
matching groups using Dunn’s t-test revealed significant
differences in NDS of the Hp−/− mice from the CCI group in
the adult age cohort (P = 0.0386), whereas 48 h after injury,
the differences between WT and Hp−/− were no longer
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FIGURE 2 | Effects of the Hp knockout on neurobehavioral outcomes following CCI in different age cohorts. (A-C) Comparison of NDS assessed at 24
and 48 h after the experimental injury between CCI-injured WT and HP−/− mice in adult and older adult age cohorts (A,B), and between CCI-injured HP−/− mice of
different ages (C) Statistical comparison of combined data presented in the (A-C) using a series of non-parametric multi-factor ANOVA with repeated measurement
structure. The numbers shown on the graphs represent P-values from the post-hoc statistical analyses performed using non-parametric Dunn’s rank sum test. (D-F)
Comparison of the circling behavior presented as the fraction of the right turns between CCI-injured WT and Hp−/− mice in adult and older adult age cohorts (D,E),
and between CCI-injured WT mice of different ages (F), respectively. Statistical comparison of combined data using mixed model multi-factor ANOVA with repeated
measurement structure. P-values shown on the graphs between two groups used for pairwise comparison were obtained from the statistical analyses using the
post-hoc Student’s t-test. In all panels, the numbers of animals per CCI experimental groups of WT and Hp−/− mice used for analyses were as follows: n = 6 and n =
18 in the adult mice age cohort (2–4 mo-old), and n = 16 and n = 13 in the adult mice age cohort (2–4 mo-old), and n = 13 and n = 5 in the older adult mice age
cohort (7–8 mo-old), respectively.
significant, suggesting possible neurological deterioration.
Significantly lower values in the Hp−/− group in the adult
mice cohort suggest an improved neurological outcome 24 h
after experimental injury, whereas no significant differences in
the NDS were observed between WT and HP−/− CCI-injured
mice in the older adult cohort at the 24 and 48 h time points
(Figure 2B). There was a significant difference between the
NDS in the CCI-injured mice from the adult and older adult
cohorts 24 h after injury (P = 0.0094), whereas at 48 h, the
increase in the NDS was also no longer significant (Figure 2C).
In addition, to determine possible effects of surgery alone on
the neurobehavioral outcomes in Hp−/− mice at the two ages,
the NDS test was performed in small groups of animals that
underwent sham surgery (n = 4 in adult and n = 2 in older
adult cohorts). The data revealed no substantial increases in
NDS scores in sham Hp−/− mice, which ranged from 0 to 1 in
adult and from 0 to 4 in the older adult cohort at 24 and 48 h
time points (data not shown). No circling behavior was detected
in any Hp−/− group after CCI, and no significant differences
were observed betweenWT and Hp−/− mice in both age cohorts
(Figures 2D,E) or between different age cohorts of Hp−/−
mice (Figure 2F), although a significant temporal effect (p =
0.0009) on the moving symmetry was revealed by mixed model
multi-factor ANOVA.
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Effects of the Hp Knockout on Anatomical
Outcomes Following CCI in the Different
Age Cohorts
In the first set of experiments, we performed tests to determine
differences in anatomical deficits after CCI in 2–4 (adult) and
7–8-mo-old (older adult) WT mice; subsequent comparisons
were then made between WT and Hp−/− mice in each age
cohort. Macroscopically, the overall brain pathology from CCI
with mild-to-moderate TBI parameters 48 h post-injury was
characterized by neuronal death, loss of cortical tissue, and, to
a lesser degree, partial loss of hippocampal tissue or hippocampal
distortion with altered structural tissue integrity as compared
to the contralateral hippocampus or hippocampi of animals
from the sham-injury group. These anatomical brain changes are
consistent with our previous published data using the same CCI
parameters (Glushakov et al., 2013, 2014, 2015).
Figures 3A,B demonstrate representative microphotographs
of brain sections obtained from WT sham and CCI-injured
animals in the two age cohorts. At the 48 h time point
in the adult and older adult age cohorts, CCI consistently
produced significant anatomical pathologies in the cortex
assessed by cresyl violet histo-stereological analysis, including
cortical lesions and complete loss of brain tissue. Cortical lesions
were characterized by morphological alternations, including
characteristic changes in cellular morphology and cell density.
These changes primarily reflect neurodegenerative processes,
neuronal death, and the presence of diffuse parenchymal
hemorrhages, which are representative of microvascular injury in
cortical tissue surrounding the impacted area. In sham animals
of both age cohorts, no (or only marginal) alterations were
observed in the cortical tissue histology due to craniotomy
surgery. Figures 3C,D represent analyses of distribution of
contusion volume between volumes of lesioned cortical tissue
and cavitation in CCI animals compared to the sham group.
To determine possible changes in the patterns of brain lesions
following experimental TBI, the injury volumes were analyzed
by measuring and statistically comparing the volumes of cortical
lesions and cavitation separately, and the data are presented as a
contingency graph.
Cortical lesions were defined as histological alterations
evident with cresyl violet staining, including cell loss (i.e., light
stromal staining without or with markedly decreased nuclear
staining), changes in cellular density and nuclear morphology
(i.e., altered shape, shrinkage, and intensively stained and
condensed nuclei), “penumbra” (i.e., the area adjusted to the
injury core with evident signs on secondary injuries such
as the aforementioned morphological changes), and small
hemorrhages, whereas cavitation was defined as total loss of brain
tissue or hematoma without visible cresyl violet staining. The
measurements were made in brain segments between bregma
coordinates from 0 to −2 mm, which covered all major brain
segments including hippocampus and cortical regions associated
with functional neurobehavioral outcomes. To compare the
differences in cortical lesion, cavitation, and total contusion
volumes between surgery groups (i.e., sham and CCI) and
animal age, statistical analyses were performed usingmulti-factor
ANOVA and post-hoc Student’s test for pairwise comparison.
The results demonstrate significant differences in all measures
of cortical injury volume in CCI groups compared to sham-
operated mice in both age cohorts (Figures 3C,E). There were
significant effects of both factors (i.e., surgery type and age) on
the cortical lesion and total contusion volumes (<0.0001 and P
= 0.0003, respectively) and a significant effect of surgery factor
on the cavitation volume measured (P = 0.0001). There was
a statistically significant difference in cortical lesion volumes
between CCI groups of the adult and older adult cohort (P =
0.0248), whereas there was no statistical difference between
cavitation and total contusion volumes measured in these groups
(Figure 3E). Interestingly, some marginal alterations in the brain
that might be characterized as cortical lesions were observed
in some animals from sham-surgery groups and there was a
significant difference between the volumes of these lesions in
sham groups of adult and older adult cohorts (P = 0.0017).
In most of the animals from the CCI groups in both
age cohorts, morphological distortion of ipsilateral hippocampi
and localized hippocampal edemas were noticeable on all
brain sections where the hippocampus is present, with the
most apparent presentation on the sections between about 1
and 2.5 mm posterior from the bregma. In some animals,
hippocampal swelling was not obvious; ipsilateral hippocampus
size was possibly reduced due to concurrent neuronal tissue
degeneration (Glushakov et al., 2015). Two-way ANOVA and
post-hoc comparison using Student’s t-test revealed no significant
changes in hippocampal volumes compared to sham in adult and
older adult cohorts (Figures 3F,G). The analyses of hippocampal
swelling has also demonstrated that the values of relative
hippocampal volumes 48 h following CCI were not significantly
different between WT mice from the adult and older adult
cohorts (Figure 3H).
Figures 4A,B demonstrate examples of brain sections within
the same bregma coordinates (from −1 mm to −2 mm)
showing typical variability of anatomical brain pathologies
between individual animals in WT and Hp−/− mice of adult
and older adult cohorts. To compare the differences between
anatomical outcome measures including cortical injury volume
(i.e., cortical contusion, cortical lesions, and cavitation) and
hippocampal swelling inWT andHp−/−mice in two age cohorts,
a multi-factor ANOVA and post-hoc pairwise comparison was
performed using Student’s test. The statistical analyses revealed
the significant interaction of age and genotype in cortical lesion
volume measures following CCI (P = 0.0172). The quantitative
analyses revealed that there were no statistical differences
between total contusion volumes of WT and Hp−/− mice in
both age cohorts (Figures 4C,D) and between Hp−/− mice from
adult and older adult cohorts (Figure 4E). Similarly, comparing
hippocampal volumes in CCI-injured animals revealed no
statistically significant differences between WT and Hp−/− mice
in any age cohort or between Hp−/− mice from adult and older
adult cohorts (Figures 4F–H). Interestingly, in the older adult
age cohort, although total cortical lesion was not significantly
different between WT and Hp−/− mice, the volume of cortical
lesions in Hp−/− was significantly increased compared to WT
mice (P = 0.0365). There was no significant difference observed
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FIGURE 3 | Age-dependent effects of the experimental TBI on anatomical outcomes. (A,B) The representative microphotographs of cresyl violet-stained brain
sections obtained at 48 h after CCI and sham injury in adult and older adult WT mice, respectively. In each panel, three brain sections were cut from the same mouse
within 1 mm apart posteriorly from the bregma (coordinates from 0 to −4 mm). The text and numbers denotes approximate distance from the bregma in posterior
direction. Areas filled with red represent cavitation and red dotted lines represent boundaries of cortical lesions and cavitation areas used for quantitative
histopathological analyses. (C-E) Comparison of lesion volumes between sham- and CCI-injured WT mice in adult and older adult age cohorts: (C,D) and between
(Continued)
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FIGURE 3 | Continued
CCI-injured WT mice of different ages (C), respectively. (F-H) Comparison of relative hippocampal volumes between sham- and CCI-injured WT mice in adult and
older adult age cohorts (C,D), and between CCI-injured WT mice of different ages (E), respectively. The numbers shown on the graphs represents P-values from the
multi-factor ANOVA an post-hoc statistical analyses performed using Student’s t-test to compare values between matched groups (n = 5−10).
between volumes of cavitation in these groups. Only marginal
anatomical alteration was detected in sham Hp−/− mice in both
adult and older adult cohorts (data not shown).
Effects of the Hp knockout on Astrocytic
and Microglial Responses Following CCI in
the Different Age Cohorts
Because the changes in glial responses to the CCI injury
reflected in proliferation of glial cells and upregulation of
specific markers are not definitely evident on the cresyl violet-
stained sections, to study the prospective effects of Hp on
the activation of reactive astrocytes and microglial cells, the
GFAP and Iba1 immunostainings were performed on the brain
sections obtained from WT and Hp−/− mice of two age
cohorts, respectively. At 48 h after CCI, there was an apparent
increase in immunoreactivity for both glial markers, glial cell
proliferation, and changes in morphology of corresponding glial
cells. Figures 5, 6 demonstrate representative microphotographs
of GFAP- and Iba1-immunostained brain sections in two
age cohorts, respectively, including zoomed selected areas of
brain sections with the most extensive glial responses to the
experimental TBI to demonstrate characteristic alteration in
glial cell morphology. The morphological examination suggested
some tendencies in the increased GFAP and Iba1 and in
contralateral and ipsilateral brain regions of Hp−/− mice
of both age cohorts. The findings of immunohistochemical
experiments in adult WTmice are consistent with our previously
published data showing significant increases in GFAP and Iba1
immunoreactivity in CCI compared to sham-injured animals.
To assess the level of astrocytic and microglial activation, first,
quantitative immunohistochemical analyses were performed
separately in the major brain segments located within the CCI
impact area with increments of 1 mm starting from the bregma
(a total of four segments from 0 to −4 mm). However, the
results revealed that there were no significant differences between
relative immunoreactivities in 1-mm-thick segments within any
brain region (multi-factor repeated measurement ANOVA with
post-hoc Student’s t-test; data not shown). Thus, we performed
further analyses using the relative immunoreactivity values
averaged for all four segments. Figure 7 demonstrates a summary
of the results of quantification of immunohistochemical stainings
shown in Figures 5, 6. The comparison of GFAP and Iba1
immunostainings between WT and Hp−/− mice in adult and
older adult cohorts revealed that the results of statistical analyses
are demonstrated in Figure 7 as P-values above bar graphs
between corresponding groups and above horizontal bars in
selected panels to show the significant difference between groups
of the same genotype from different age cohorts (ANOVA with
post-hoc Student’s t-test).
DISCUSSION
This study examined for the first time the potential roles
of the Hp pathway in TBI using two age cohorts of WT
and Hp−/− mice. The results suggest that the role of Hp
in TBI is multi-factorial and age dependent. Because Hp is
involved in clearance of generally toxic free hemoglobin and
has antioxidant properties (Campbell et al., 2005), its injury-
induced upregulation would contribute to the neuroprotective
compensatory mechanism (Vejda et al., 2002). Although there
is no clear consensus, preclinical studies from Dr. J. Aronowski
and his colleagues have suggested that Hp might be expressed in
the brain and its induction would be sufficient to be protective in
experimental intracerebral hemorrhage (Zhao et al., 2009, 2011).
The results of our study suggest that global deletion of the Hp
gene is associated with statistically significant better short-term
functional outcomes following experimental TBI in 2–4 mo-old
(adult) mice, whereas no such effects were observed betweenWT
and Hp−/− 7–8 mo-old (older adult) mice, and there were no
statistical differences between volumes of total contusion, cortical
lesions, and tissue loss in WT and Hp−/− of both age cohorts.
Statistical differences were also observed in the gliosis outcomes,
i.e., astrogliosis and microgliosis.
Hp is involved in the acute phase response to systemic or local
tissue injuries by cytokine-triggered hepatocytic synthesis and
release into circulation of several defensive proteins (Wilcockson
et al., 2002; Petersen et al., 2004; Campbell et al., 2005). Although
limited preclinical studies provide evidence that Hp might be
expressed in the brain (Zhao et al., 2009, 2011), it is more likely
that increased CSF and brain levels of Hp observed after TBI
might essentially result from blood-brain-barrier breakdown (Liu
and Sturner, 1988; Bell et al., 1997). It has long been recognized
that elevated serum Hp after TBI is produced mainly from the
liver (Bowman and Kurosky, 1982; Hoj et al., 1984; Yang et al.,
2013) it peaks approximately 24 h after injury and its levels
are associated with increased cytokine levels (Bell et al., 1997;
Amick et al., 2001). The latter observation is also supported by
a previous immunohistochemical clinical study performed in the
post-mortem brain of TBI patients that provided solid evidence
that the spatiotemporal profiles of increased levels of Hp and
several other plasma proteins are associated with blood-brain
barrier breakdown and the extravasated plasma proteins and
their subsequent uptake by the glial cells (Liu and Sturner, 1988).
However, there is evidence of complex roles of Hp expression and
its phenotypes in different types of brain injuries. Hp is a potent
antioxidant and its increased expression has been documented in
different brain injuries that are not directly associated with brain
hemorrhages. Experimental studies have documented significant
changes in Hp expression in the plasma of rats undergoing
experimental transient focal cerebral ischemia (Chen et al., 2011).
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FIGURE 4 | Effects of the Hp knockout on anatomical outcomes following CCI in different age cohorts. (A,B) The representative microphotographs of
cresyl violet-stained brain sections obtained at 48 h after CCI in adult and older adult WT and Hp−/− mice, respectively. In each panel, three examples of the brain
sections from three different animals from the same experimental group (marked as Mouse #1–3). The example brain section from each mouse was cut within
coordinates from −1 to −2mm. Areas filled with red represent cavitation and red dotted lines represent boundaries of cortical areas covered by cortical lesions used
for quantitative histopathological analyses. (C-E) Comparison of the lesion volumes between CCI-injured WT and Hp−/− mice in the adult and older adult age cohorts
(C,D), and between the CCI-injured WT mice from different age cohorts
(Continued)
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FIGURE 4 | Continued
(E), respectively. (F-H) Comparison of relative hippocampal volumes between WT and Hp−/− CCI-injured mice in adult and older adult age cohorts (C,D), and
between CCI-injured Hp−/− mice of different ages (E), respectively. The numbers shown on the graphs represents P-values from the multi-factor ANOVA an post-hoc
statistical analyses performed using Student’s t-test to compare values between matched groups (n = 4−10).
FIGURE 5 | Effects of Hp on the reactive astrocyte immunoreactivity at 48h after CCI in 2–4 mo-old (adult) and 7–8 mo-old (older adult) mice. (A,B) The
representative microphotographs of GFAP immunostainings in the “penumbral” part of the primary somatosensory area (SSp) of cerebral cortex, posterior part of
cortical amigdalar areas, lacunosum-moleculare (CA1slm), and stratum radiatum (CA1sr) fields of hippocampal CA1 area, lateral dorsal nucleus (LD) of thalamus.
Identification of the brain structures and usage of the histological acronyms in this and other figures were achieved using Allen Mouse Brain Atlas (Lein et al., 2007).
In a TBI model, Hp phenotypes were associated with differential
neuropsychological outcomes; however, in contrast to clinical
and preclinical data in subarachnoid brain hemorrhage, the
“high” affinity Hp 1-1 phenotype was associated with worse
outcomes (Anderson et al., 2009).
The neurological outcomes assessed using NDS and
anatomical outcomes (i.e., brain lesions and cortical tissue) in
adult WT mice observed in this study were consistent with our
previously published data obtained in C57BL/6 mice within this
age range (Glushakov et al., 2013, 2014, 2015). Not surprisingly,
the NDS was increased in older adult mice of both WT and
Hp−/− genotypes in the experiments with the same magnitude
of the experimental TBI. In the sham group, WT mice from
the 7–8 mo-old older adult cohort had a range of NDS that was
seemingly higher compared to that observed in WT 2–4 mo-old
adults from the sham group normally showing no detectable
or only marginal neurological deficits, although there were no
statistically significant differences between sham groups of WT
mice from these two age cohorts. This observation suggests
that some older adult animals have increased vulnerability to
surgical procedures, including craniotomy performed in the
sham groups. However, no such changes in the NDS variability
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FIGURE 6 | Effects of Hp knockout on the activated microglia immunoreactivity at 48h after CCI in 2–4 mo-old (adult) and 7–8 mo-old (older adult)
mice. (A,B) The representative microphotographs of Iba1 immunostained brain sections. The acronym definitions are the same as those in the legend of Figure 5.
were observed in the sham Hp−/− mice from both age cohorts
and the ranges of NDS in these mice were within the range of
2–4 mo-old WT mice from the sham group.
Based on analyses of cresyl violet-stained sections, significant
cortical and hippocampal pathologies were evident at the 48
h time point used in this study in all CCI-injured groups.
The anatomical cortical injury was quantified as a cortical
contusion volume, which was identified by characteristic tissue
loss of brain tissue, neuronal death, and alteration in cellular
morphology and integrity of brain structures and intracerebral
hemorrhages. As we previously reported, in the CCI model,
based on evident alterations in the hippocampus that are not
directly affected by impact, the overall brain lesions could be
categorized into two groups with prevalence reflecting severity
of secondary injuries: type I and II, which are characterized by
morphopathological changes in the ipsilateral hippocampus with
remaining structural organization and by a complete loss of the
ipsilateral hippocampus, respectively (Glushakov et al., 2015).
The cortical cavitation is characteristic of both of these lesion
types, although it is more prominent with later injury-onset time
points (Glushakov et al., 2013).
It is well recognized that neuronal death and loss of brain
tissue reflects secondary injury predominantly resulting from
necrotic calpain-induced proteolysis (Wang et al., 2006; Saatman
et al., 2010). In addition, our previous data have shown that the
overall brain lesions might be categorized by the changes in the
hippocampal morphology with seemingly abrupt transformation
from hippocampal edema to hippocampal degeneration (lesion
types I and II, respectively) resulting either from increasing
severity of impact (e.g., increased compression distance) or
from the deleterious effect of pharmacological intervention even
with mild-to-moderate initial impact reflecting the severity of
secondary injuries (Glushakov et al., 2015).
CCI parameters used in this study allowed one to induce brain
injury by partial direct compression of the cortical tissue with
rigid impactor, whereas the brain structures located underneath
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FIGURE 7 | Quantification of GFAP and Iba1 immunoreactivities at 48h after CCI in in 2–4 mo-old (adult) and 7–8 mo-old (olde adult) mice. The bar
graphs show quantitative analyses of GFAP (A) and Iba1 (B) immunostained brain sections presented as relative immunoreactivity of in the selected ipsilateral brain
regions (shown in the Figures 5, 6) normalized to the immunoreactivity values calculated in their contralateral counterparts. The numbers above bars in each graph
represents P-values obtained by using multi-factor ANOVA and the post-hoc Student’s t-test (n = 4–8). *indicates significant difference.
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the cortical injury site are affected indirectly and with gradient
decreasing pressure that likely would not cause meaningful
mechanical damage. However, in this study, the prevalence
of hippocampal alterations in most animals reflected type-I
lesions, which are characterized by a marked increase in the
ipsilateral hippocampal volume and distortion of hippocampal
shape without substantial loss of hippocampal tissue, while in
some animals, the ipsilateral hippocampi were of comparable size
and shape or even had some reduction of ipsilateral hippocampal
size, suggesting variability in ranges of responses to injury in
individual animals.
Immunohistochemical experiments with GFAP and Iba1
stainings performed at the 48 h time point after experimental TBI
revealed significant proliferation and changes in cell morphology
of reactive astrocytes and activated microglial cells in selected
brain regions consistent with our previous published data
obtained with the same experimental parameters (Glushakov
et al., 2013, 2014). The upregulation of these immunomarkers
and proliferation of glial cells were observed in cortical lesioned
tissue, including “penumbral” areas, located underneath the
injury, and evident with histophatological examination using
cresyl violet staining; and also, to a lesser extent, in the
brain regions not directly affected by the CCI impact without
evident histopathological changes (cresyl violet) throughout the
whole ipsilateral cerebral cortex even with seemingly similar
immunoreactivity intensity and cellular morphology up to distal
cortical amigdalar areas; and ipsilateral brain structures that
are not directly impacted, including the hippocampus, and
some areas of the thalamus and striatum. The results of these
experiments indicate that there were differences in microglial
and astrocytic reactivity between Hp−/− and WT in selected
brain regions of the adult but not older adult age cohort,
suggesting that Hp might be involved in glial or inflammatory
responses, or affecting secondary injuries to the levels that are
reflected in changes in upregulation of astrocytic and microglial
markers or proliferation of glial cells. There were also some
apparent tendencies in the upregulation of glial cells in selected
contralateral regions of Hp−/− mice of both age cohorts that
might result from presumed impairment of overall defensive
mechanisms due to deletion of Hp; establishing their potential
clinical importance in brain injuries requires more detailed
investigation. Although reactive astrocytes have been implicated
in playing a role in the uptake of Hp and other extravasated
plasma proteins (Liu and Sturner, 1988) the result of GFAP, as
well as Iba1, IHC experiments in Hp−/− did not support the
astrocytic or microglial involvement in clearance of assumed Hp-
hemoglobin complexes following TBI. The roles of astrocytes
microglia in brain injury are complex, including both beneficial
and detrimental effects (Loane and Byrnes, 2010). On the
other hand, it is also recognized that increased upregulation of
astrocytic and microglial markers is associated with the extent of
anatomical and behavioral deficits. In our study, the significantly
decreased upregulation of GFAP and Iba1 in selected brain
regions of Hp−/− mice may indicate involvement of Hp in these
inflammatory responses. The effect of aging in experimental
models of TBI is well recognized, including neurological
outcomes, neuronal brain pathology, and blood-brain barrier
function (Onyszchuk et al., 2008; Sandhir et al., 2008; Lee et al.,
2012; Timaru-Kast et al., 2012). However, little is known about
the effects of Hp expression on brain injuries, and in our study,
we have made an attempt to uncover possible dependencies
of Hp roles with age using WT and Hp−/− mice. The results
of this study revealed significant associations of both age and
genotype factors with several neurobehavioral, anatomical, and
immunohistochemical outcome measures. Interestingly, the data
suggest that improved NDS in Hp−/− might be associated
with decreased upregulation of both GFAP and Iba1 in the
cortical areas located adjacent to the injury site and Iba1
upregulation in selected hippocampal and striatal regions in adult
CCI-injured mice. However, these effects of Hp deletion were
lost with aging.
In terms of some limitations of this study, although we believe
that using of Hp−/− mice is one of the currently reasonable
available approaches to test our hypotheses, the use of genetically
modified mice, in general, has inherent limitations due to
activation of possible compensatory mechanisms to restore the
organism’s functions. In particular, it might be critical in case of
“protective” proteins such as Hp that might potentially affect the
physiological state and affect responsiveness to the experimental
injury. Thus, some differences in the outcomes in adult and
older adult mice might be attributed to the chronic ablation of
a component of the acute phase response system. In addition, the
translational potential of this study might be limited because of
the heterogeneity of human Hp phenotypes in contrast to the
homogeneity of Hp in mice and other animals, and thus using
animal models may not reflect the whole spectrum of the various
Hp-involving pathways. Another limitation of the study is using
only an acute time point with the given experimental conditions
reflecting only the Hp roles in short-term outcomes, whereas
some results of our study suggest that long-term outcomes might
be different.
In conclusion, this study provides an insight into the
prospective roles of Hp in TBI and other acute brain injuries,
especially those with complex mechanisms. The data of this study
suggest that systemic Hp might interact with the intrinsic brain’s
mechanisms of hemoglobin clearance and/or antioxidative
protective pathways affecting short-term clinical outcomes. The
data also suggest that ablation of Hp might affect the organism’s
responsiveness to brain injuries and this effect is more prominent
with aging. In addition, these results might be implicated in
understanding the inconsistency in outcomes of clinical studies
regarding the importance of Hp phenotypes in brain injuries.
However, the potential roles of Hp in long-term outcomes
warrant additional studies.
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